Search PubMed⌕ Search

Biomedical subjects

H L Davis

Publications and source records attributed to H L Davis.

At least 145 records · Page 8Linked to original sources
PubMed1975

Improved method for the simultaneous determination of phenobarbital, primidone and diphenylhydantoin in patient's serum by gas-liquid chromatography.

A quantitative gas-liquid chromatographic method for the simultaneous determination of phenobarbital, primidone and diphenylhydantoin in human serum is described. A double extraction is employed to improve the removal of interfering substances. The N,N-dimethyl derivatives of the compounds are prepared by "oncolumn" methylation with 50% Methelute. Decomposition of phenobarbital to N-methyl-a-phenylbutyramide was negligible if the contact time with Methelute was less than 10 min. The drugs were stable in serum for at least two weeks. This procedure provides a rapid, sensitive, selective and accurate method for the routine determination of serum concentrations of three of the most commonly prescribed anticonvulsant drugs.

Anticonvulsants↗
PubMed1975

Clinical and theoretical aspects of the treatment of surgically unresectable retroperitoneal malignancy with combined intra-arterial actinomycin-D and radiotherapy.

A small pilot series (eight patients) of surgically unresectable retroperitoneal tumors treated with radiotherapy and a selective, prolonged, continuous intra-arterial infusion of actinomycin-D is discussed, in addition to the possible theoretical advantages for this therapy. For such tumors, there is a very low probability of obtaining local control with conventional radiotherapy alone. However, on the basis of recent knowledge from radiobiology and molecular biology, the technique is a rational attempt to improve the local control probability. Geographic miss with radiotherapy portals is another major cause for local failure with such tumors. We also emphasize the importance of detailed tumor localization procedures. The local responses, some of the local controls, the palliation achieved, and the lack of significant morbidity with this technique have been encouraging. We therefore consider it worthy of further clinical investigation.

Adolescent↗
PubMed1975

Further clinical studies with intrahepatic arterial infusion with 5-fluorouracil.

A total of 419 patients with progressive liver disease, in nearly all cases metastatic from gastrointestinal primaries, were treated by intrahepatic arterial infusion with 5-FU. Three-fourths of these patients had had prior trials with intravenous 5-FU for 1 or 2 months to several years and had been switched to the infusion upon the development of progression. Catheters were placed percutaneously and the patients infused with 5-FU at a dose of 20 to 30 mg/kg/day X 4, then 15 mg/kg/day X 17, at which point the catheter was removed and the patient sent home on weekly i.v. doses at 15 mg/kg. Toxicity, morbidity, and mortality were minimal with the intrahepatic arterial infusion treatment and the rigid criteria of improvement were met by 55% of the study cases. The survival rate of those patients who responded to the treatment was greater than the survival rate of those who failed to respond.

Fluorouracil↗